Skip to main content
. Author manuscript; available in PMC: 2009 Jan 24.
Published in final edited form as: Vaccine. 2007 Dec 3;26(4):502–508. doi: 10.1016/j.vaccine.2007.11.034

Table 3.

α C Protein-Specific IgM and IgG Concentrations in Acute and Convalescent Sera from Women with Invasive Disease Caused By α C-Expressing Strains of GBS

Patient Age (yr)/ethnicity Diagnoses Days of documented bacteremia CPSa type Days after diagnosis α C-specific IgM (ng/ml) α C-specific IgG (ng/ml)
1 26/Black Bacteremia, chorioamnionitis at delivery of healthy term infant 1 Ia 0 896 79
2 712 48
23 742 97
2 30/Asian Bacteremia, chorioamnionitis at delivery of healthy term infant 2 Ib 2 683 1245
23 1264 6433
3 20/Black Endocarditis with mitral ring abscess; saline abortion 12 days prior to evaluation 1b IV 4 788 620
15 616 673
30 1364 1459
51 209 1061
4 18/White Septic pelvic vein thrombophlebitis; retained placenta (27 days) following delivery of healthy 32 week neonate; insulin-dependent diabetes 3 Ib 16 8808 771,748
5 36/White Osteomyelitis of cervical vertebrae diagnosed 87 days after delivery of healthy term infant 0 Ia 49 405 1802
a

CPS, capsular polysaccharide

b

Blood culture was not reassessed until 9 days after initial positive cultures (5 of 5) for GBS on the day of admission